Pharmalot... Pharmalittle... Good Morning

Top of the morning to you. A glorious sun is warming the chilly Pharmalot corporate campus this morning, where the official mascots are harassing the wild life, the short people are scurrying off to their houses of learning and we are brewing yet another cup of needed stimulation. Although we sense that the world may be slowing down as holiday time nears for many, we remain as busy as ever, which is a good thing. So here are a few items of interest to get you started. Hope you have a smashing day and do stay in touch if you hear anything fascinating... Study Shows Mixed Links Between Antidepressants And Autism (MedPage Today) FDA Approves Glaxo And Theravance Drug For COPD (Reuters) FDA And EMA To Team Up For Generic Inspections (Pharma Times) Gilead Releases Impressive Results For Its Hepatitis C Drug (Reuters) API Maker Fined For Exposing Workers To Hazardous Chemicals (InPharma Technologist) Daiichi Commits To Helping Ranbaxy Meet FDA Regs (The Hindu Business Line) Bayer To Buy Cancer Drug Partner Algeta For $2.9 Billion (Reuters) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs